Search Results - "BURNETT, J. C"

Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial by Blair, John E.A., Pang, Peter S., Schrier, Robert W., Metra, Marco, Traver, Brian, Cook, Thomas, Campia, Umberto, Ambrosy, Andrew, Burnett, John C., Grinfeld, Liliana, Maggioni, Aldo P., Swedberg, Karl, Udelson, James E., Zannad, Faiez, Konstam, Marvin A., Gheorghiade, Mihai

“…Aim To provide an in-depth clinical characterization and analysis of outcomes of the patients hospitalized for heart failure (HF) who subsequently develop…”
Get full text

PTH: Potential role in management of heart failure by Gruson, D., Buglioni, A., Burnett, J.C.

“…Biomarkers play an important role for the diagnosis and prognosis of heart failure (HF), a disease with high morbidity and mortality as well as a huge impact…”
Get full text

Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway by Bordicchia, M, Ceresiani, M, Pavani, M, Minardi, D, Polito, M, Wabitsch, M, Cannone, V, Burnett, Jr, J C, Dessì-Fulgheri, P, Sarzani, R

“…Cardiac natriuretic peptides (NP) are involved in cardiorenal regulation and in lipolysis. The NP activity is largely dependent on the ratio between the…”
Get more information

Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study by Chen, H H, Martin, F L, Gibbons, R J, Schirger, J A, Wright, R S, Schears, R M, Redfield, M M, Simari, R D, Lerman, A, Cataliotti, A, Burnett, Jr, J C

“…B-type natriuretic peptide (BNP, nesiritide) has anti-fibrotic, anti-hypertrophic, anti-inflammatory, vasodilating, lusitropic and aldosterone-inhibiting…”
Get more information

Effects of tolvaptan on dyspnoea relief from the EVEREST trials by Pang, Peter S., Konstam, Marvin A., Krasa, Holly B., Swedberg, Karl, Zannad, Faiez, Blair, John E.A., Zimmer, Christopher, Teerlink, John R., Maggioni, Aldo P., Burnett, John C., Grinfeld, Liliana, Ouyang, John, Udelson, James E., Gheorghiade, Mihai

“…Aims To describe the effects of tolvaptan therapy on dyspnoea relief based on timing of delivery, influence of concomitant therapies, and baseline patient and…”
Get full text

Natriuretic peptide levels in Atrial fibrillation : A prospective hormonal and doppler-echocardiographic study by ROSSI, A, ENRIQUEZ-SARANO, M, BURNETT, J. C, LERMAN, A, ABEL, M. D, SEWARD, J. B

“…The objective was to determine the independent association between atrial fibrillation (A-Fib) and activation of natriuretic peptides. The association of A-Fib…”
Get full text

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans by LERMAN, A, BURNETT, J. C, HIGANO, S. T, MCKINLEY, L. J, HOLMES, D. R

“…Coronary endothelial dysfunction is characterized by an imbalance between endothelium-derived vasodilating and vasoconstricting factors and coronary…”
Get full text

Pharmacophore-guided lead optimization: The rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease by Burnett, J.C., Wang, C., Nuss, J.E., Nguyen, T.L., Hermone, A.R., Schmidt, J.J., Gussio, R., Wipf, P., Bavari, S.

“…The 3-zone pharmacophore for botulinum neurotoxin serotype A metalloprotease inhibition guided the design of a potent regioisomeric pair possessing a K i = 600…”
Get full text

Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy by Yamamoto, Kazuhiro, Burnett, John C, Jougasaki, Michihisa, Nishimura, Rick A, Bailey, Kent R, Saito, Yoshihiko, Nakao, Kazuwa, Redfield, Margaret M

“…Atrial and brain natriuretic peptides (ANP and BNP) are produced by the heart, and their plasma concentrations are increased in human chronic congestive heart…”
Get full text

Tumor Necrosis Factor Downregulates an Endothelial Nitric Oxide Synthase mRNA by Shortening Its Half-life by Yoshizumi, Masao, Perrella, Mark A, Burnett, John C, Lee, Mu-En

“…Nitric oxide (NO), which accounts for the biological properties of endothelium-derived relaxing factor, is generated by NO synthase (NOS). The vascular…”
Get full text

Endothelin in human congestive heart failure by CHI-MING WEI, LERMAN, A, RODEHEFFER, R. J, MCGREGOR, C. G. A, BRANDT, R. R, WRIGHT, S, HEUBLEIN, D. M, KAO, P. C, EDWARDS, W. D, BURNETT, J. C

“…Although recent investigations report the elevation of plasma endothelin (ET) in congestive heart failure (CHF), it remains unclear if this elevation is that…”
Get full text

Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial by Ambrosy, Andrew P, Pang, Peter S, Khan, Sadiya, Konstam, Marvin A, Fonarow, Gregg C, Traver, Brian, Maggioni, Aldo P, Cook, Thomas, Swedberg, Karl, Burnett, Jr, John C, Grinfeld, Liliana, Udelson, James E, Zannad, Faiez, Gheorghiade, Mihai

“…Signs and symptoms of congestion are the most common cause for hospitalization for heart failure (HHF). The clinical course and prognostic value of congestion…”
Get full text

Renal localization and actions of adrenomedullin: a natriuretic peptide by Jougasaki, M, Wei, C M, Aarhus, L L, Heublein, D M, Sandberg, S M, Burnett, Jr, J C

“…Adrenomedullin (ADM) is a newly described 52-amino acid peptide originally isolated from extracts of human pheochromocytoma and, more recently, detected in…”
Get full text

Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population by Luchner, Andreas, Burnett, John C, Jougasaki, Michihisa, Hense, Hans-Werner, Heid, Iris M, Muders, Frank, Riegger, Gänter A.J, Schunkert, Heribert

“…OBJECTIVETo evaluate brain natriuretic peptide (BNP) as marker of left ventricular (LV) dysfunction and hypertrophy in a population-based sample of 610…”
Get full text

Elevation of circulating and ventricular adrenomedullin in human congestive heart failure by JOUGASAKI, M, CHI-MING WEI, MCKINLEY, L. J, BURNETT, J. C

“…Adrenomedullin (ADM) is a newly discovered vasodilating and natriuretic peptide that may play an important role in cardiorenal regulation. Although ADM was…”
Get full text

Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans by LERMAN, A, HOLMES, D. R, BELL, M. R, GARRATT, K. N, NISHIMURA, R. A, BURNETT, J. C

“…The endothelium modulates vascular tone through release of vasodilating substances, such as endothelium-derived relaxing factors, and vasoconstricting…”
Get full text

Natriuretic peptide system in human heart failure by Wei, C M, Heublein, D M, Perrella, M A, Lerman, A, Rodeheffer, R J, McGregor, C G, Edwards, W D, Schaff, H V, Burnett, Jr, J C

“…Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP) are a family of structurally related peptides that…”
Get full text

Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study by Luchner, Andreas, Burnett, John C., Jougasaki, Michihisa, Hense, Hans-Werner, Riegger, Günter A.J., Schunkert, Heribert

“…Objectives. The present retrospective analysis of data derived from a population-based study examined the relationship between intake of beta-receptor…”
Get full text

Circulating and Tissue Endothelin Immunoreactivity in Advanced Atherosclerosis by Lerman, Amir, Edwards, Brooks S, Hallett, John W, Heublein, Denise M, Sandberg, Sharon M, Burnett, John C

“…ATHEROSCLEROSIS may be initiated by endothelial injury, which then leads to the proliferation of intimal smooth-muscle cells. 1 The atherogenic smooth-muscle…”
Get full text

Vasopeptidase inhibitors: A new therapeutic concept in cardiovascular disease? by CORTI, Roberto, BURNETT, John C, ROULEAU, Jean L, RUSCHITZKA, Frank, LÜSCHER, Thomas F

“…The cardiovascular system is regulated by hemodynamic and neurohumoral mechanisms. These regulatory systems play a key role in modulating cardiac function,…”
Get full text